Tom Nolan reviews this week’s research The scale and impact of modern health care can be mind-boggling. “Approximately 93 million computed tomography (CT) examinations are performed on 62 million ...

A research team at the Technical University of Munich (TUM) has developed a method to predict early-stage kidney damage ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] ...

It is the first centre to offer the tech in Melaka and Negeri Sembilan. Malaysia’s Mahkota Medical Centre has announced the ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...

Illuccix, after radiolabelling with gallium-68, is indicated in France for the detection of prostate-specific membrane ...

suspected prostate cancer is typically confirmed by taking a biopsy of the prostate and examining it under a microscope. Further tests, such as CT scans and bone scans, may be performed to ...

An immuno-based treatment targeting cancer cells with mismatch repair-deficiency could help those with the disease treat ...

“I really can’t stress the importance of early detection enough,” he says. “Catching it early can literally add years and ...